6451 - 6500 of 8587 Results
Title
Year
-
OPENTitle: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s DiseaseJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 15Issue #: 5Start Page: 8592End Page: 8609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.1c00453Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00453Citation Count: 79
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 17
-
OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 16
-
OPENTitle: Human pegivirus alters brain and blood immune and transcriptomic profiles of patients with Parkinson’s diseaseJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.189988Best OA location URL: https://devel-insight.jci.org/articles/view/189988/files/pdfCitation Count: 0
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 63
-
OPENTitle: Personality and reported quality of life in Parkinson's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 32Issue #: 3Start Page: 324End Page: 330Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.4475Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5333497Citation Count: 24
-
OPENTitle: GBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 9Start Page: 941End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.228Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.228Citation Count: 137
-
OPENTitle: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Best OA location URL: https://doi.org/10.1016/j.isci.2024.110956Citation Count: 1
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Best OA location URL: https://www.mdpi.com/2218-273X/14/6/647/pdf?version=1717136963Citation Count: 3
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 61
-
OPENTitle: Testing the Protein Propagation Hypothesis of Parkinson DiseaseJournal Name: Journal of Experimental NeurosciencePublisher: SAGE PublicationsVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1179069518786715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1179069518786715Citation Count: 27
-
OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
-
OPENTitle: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD TrialJournal Name: Genomics, Proteomics & BioinformaticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 2Start Page: 274End Page: 287Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009Best OA location URL: https://academic.oup.com/gpb/article-pdf/20/2/274/57583888/gpb_20_2_274.pdfCitation Count: 69
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29205Citation Count: 10
-
OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15
-
OPENTitle: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populationsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: e120End Page: e124Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad247Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad247/50913645/awad247.pdfCitation Count: 1
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
-
OPENTitle: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 8Start Page: 2416End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8891344Citation Count: 48
-
OPENTitle: Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43856-025-00817-7Best OA location URL: https://www.nature.com/articles/s43856-025-00817-7.pdfCitation Count: 1
-
OPENTitle: Generation of human midbrain organoids from induced pluripotent stem cellsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1Best OA location URL: https://mniopenresearch.org/articles/3-1/v1/pdfCitation Count: 12
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 13
-
OPENTitle: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-020-04994-7Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-020-04994-7Citation Count: 16
-
RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
-
OPENTitle: Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advancesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00716-zBest OA location URL: https://www.nature.com/articles/s41531-024-00716-z.pdfCitation Count: 3
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 79
-
OPENTitle: ARSA variants in α-synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 12Start Page: e70End Page: e70Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz340Best OA location URL: https://academic.oup.com/brain/article-pdf/142/12/e70/31499429/awz340.pdfCitation Count: 19
-
OPENTitle: Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologiesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf066Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf066/61842091/fcaf066.pdfCitation Count: 0
-
OPENTitle: Targeted deletion ofGD3synthase protects againstMPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 22
-
OPENTitle: Parkin-deficient mice are not a robust model of parkinsonismJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 102Issue #: 6Start Page: 2174End Page: 2179Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0409598102Best OA location URL: http://doi.org/10.1073/pnas.0409598102Citation Count: 462
-
OPENTitle: Gender Differences in Functional Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 182End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12864Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12864Citation Count: 52
-
OPENTitle: Is Pallido‐Pyramidal Syndrome Still a Useful Concept? NoJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12843Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12843Citation Count: 2
-
OPENTitle: Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 61End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6962683Citation Count: 13
-
OPENTitle: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved OutcomesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 3Start Page: 222End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12724Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12724Citation Count: 1
-
OPENTitle: Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of DopamineJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 32End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12851Citation Count: 19
-
OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7212500Citation Count: 88
-
OPENTitle: Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunctionJournal Name: The Journal of PhysiologyPublisher: WileyVol: 599Issue #: 9Start Page: 2483End Page: 2498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jp277459Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6908773Citation Count: 25
-
OPENTitle: Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1544End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6810685Citation Count: 98
-
OPENTitle: Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 320Issue #: 11Start Page: 1151End Page: 1151Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2018.12917Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2702872/jama_ossenkoppele_2018_pc_180007.pdfCitation Count: 389
-
OPENTitle: Associations Between Tau, β-Amyloid, and Cognition in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 75Issue #: 2Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2017.3713Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2664949/jamaneurology_winer_2017_oi_170089.pdfCitation Count: 72
-
OPENTitle: Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutationsJournal Name: Molecular Biology of the CellPublisher: American Society for Cell Biology (ASCB)Vol: 29Issue #: 5Start Page: 575End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1091/mbc.e17-01-0031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6004587Citation Count: 40
-
OPENTitle: Evidence for increased completed suicide in first-degree relatives ofLRRK2G2019S mutation Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 843End Page: 844Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2018-319364Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6506381Citation Count: 0
- Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystonia2018OPENTitle: Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystoniaJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 12Start Page: 1296End Page: 1300Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2017-317098Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7498178Citation Count: 12
-
OPENTitle: Neuroanatomical phenotypes in mental illness: identifying convergent and divergent cortical phenotypes across autism, ADHD and schizophreniaJournal Name: Journal of Psychiatry and NeurosciencePublisher: CMA Joule Inc.Vol: 43Issue #: 3Start Page: 201End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1503/jpn.170094Best OA location URL: http://jpn.ca/wp-content/uploads/2018/04/43-3-201.pdfCitation Count: 71
- Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications2019RESTRICTEDTitle: Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor ComplicationsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 82End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27892Citation Count: 63
-
OPENTitle: Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat TauopathiesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 171End Page: 176Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27872Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7993399Citation Count: 64
-
RESTRICTEDTitle: Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha‐Synuclein ProfilesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 495End Page: 499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27884Citation Count: 42
-
OPENTitle: Motor Complications in Parkinson's Disease: 13‐Year Follow‐up of the CamPaIGN CohortJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 185End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.27882Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27882Citation Count: 65
-
OPENTitle: Cervical Dystonia Incidence and Diagnostic Delay in a Multiethnic PopulationJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 450End Page: 456Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27927Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10683845Citation Count: 35
-
OPENTitle: Texture Features of Magnetic Resonance Images: A Marker of Slight Cognitive Deficits in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 486End Page: 494Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27931Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27931Citation Count: 26